WASHINGTON, D.C. - (AP) AstraZeneca will pay $68.5 million as part of a multistate settlement over allegations that the drug developer promoted its blockbuster psychiatric drug Seroquel for insomnia, Alzheimer's and other unapproved uses. The New Jersey Attorney General's Office announced the agreement Thursday, describing it as the largest multistate pharmaceutical settlement. . . . Full version available to lexis.com subscribers.